Search

Search Constraints

You searched for: Author/Creator Fischer, Rieke N.

Search Results

1. Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma. (July 2019)

2. Antigen‐presenting human B cells are expanded in inflammatory conditions. Issue 2 (17th August 2016)

3. PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations. (3rd May 2016)

4. Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors. (January 2023)

5. Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment. (21st May 2020)